For free and confidential advice about alcohol and other drugs, call the National Alcohol and Other Drug hotline: 1800 250 015. It will automatically direct you to the Alcohol and Drug Information Service in your state or territory. Click here for more information
To build scope & capacity
for clinical research
NCCRED’s second national symposium on November 20, was a vital opportunity for the AoD sector to advance its collective response to emerging drugs.
The symposium focused on innovations in the therapeutic practice for methamphetamine disorder.
The symposium brought together leading national researchers, including presentations from recipients of NCCRED’s Round 2 Seed Funding Program, NCCRED Clinical Research Fellows, and NCCRED research team members, all sharing the most up-to-date aspects of their work and research around emerging drug use.
Areas of exploration in the 2020 symposium included:
Check out our full program below or catch up with all presentation recordings. Slides coming soon.
We look forward to seeing you in 2021.
David Goodman
Assistant Professor, Division of Infectious Diseases, David Geffen School of Medicine at University of California, Los Angeles, USA |
CTN-0110 (MURB): A Randomized, placebo-controlled trial of monthly injectable buprenorphine for methamphetamine use disorder with occurring opioid use. | Skip to:
6min 20sec |
Edward Mullen
NCCRED Research Fellow, Consultant Psychiatrist, Hype and Substance Use Research Group and Early Intervention Clinic |
An Open-Label Pilot Study of Subanaesthetic Ketamine for Stimulant Use Disorder – Methamphetamine Type in Youth | Skip to:
25min 20sec |
Liam Acheson
PhD Candidate, National Drug and Alcohol Research Centre (NDARC), University of New South Wales, Research Officer, Alcohol and Drug Service, St Vincent’s Health Sydney |
Lisdexamfetamine for the management of acute methamphetamine withdrawal: Protocol for an open-label safety and feasibility study | Skip to:
38min |
Robert Ali
Chair, NCCRED Methamphetamine and Emerging Drugs Clinical Research Network Working Group, Clinical Associate Professor in the Discipline of Pharmacology at the University of Adelaide |
Discussant | Skip to:
51min 20 sec |
Alison Beck
Trial Coordinator, Clinical Psychologist, School of Psychology, University of Wollongong |
Methamphetamine and mutual support: A mixed methods exploration of SMART Recovery participants’ characteristics and opportunities for enhanced referral pathways | Skip to:
2min 30 sec |
Victoria Manning
Head of Research and Workforce Development, Turning Point, Eastern Health, Associate Professor of Addiction Studies, Monash University |
The methamphetamine approach-avoidance training (MAAT) trial: A randomised controlled trial of personalised approach bias modification for methamphetamine use | Skip to:
12 min 50 sec |
Adam Rubenis
NCCRED Research Fellow, Psychologist, Statewide Clinical Services, Turning Point (Eastern Health) |
Collaborative development of a clinician-administered checklist to facilitate retention and therapeutic engagement in substance use treatment | Skip to:
25 min 45 sec |
Rachel Reilly
Senior Research Fellow, Novel Interventions to Address Methamphetamine Use in Aboriginal and Torres Strait Islander Communities (NIMAC), Infection and Immunity Aboriginal Health, South Australian Health and Medical Research Institute (SAHMRI) |
An acceptability and feasibility study of the We Can Do This online therapeutic program in primary care and residential rehabilitation settings | Skip to:
34 min 40 sec |
Annalee Stearne
Chair, NCCRED Aboriginal and Torres Strait Islander Working Group, & NCCRED Board member Research Associate/ PhD Candidate, National Drug Research Institute |
Discussant | Skip to:
45 min 55 sec |
Emma Black
Senior Project Officer, Drug and Alcohol Services, South Eastern Sydney Local Health District, The Langton Centre |
Developing a clinical data laboratory for methamphetamine use in NSW: The MAData project | Skip to:
1 min 25 sec |
Llewellyn Mills
Honorary Research Fellow, Central Clinical School, Faculty of Medicine |
Impact of Amphetamine Type Stimulant Use on Clinical Outcomes in OTP Clients | Skip to:
12 min 30 sec |
Krista Siefried
Deputy Director & Clinical Research Lead, National Centre for Clinical Research on Emerging Drugs (NCCRED) |
Clinical outcomes and measures used in randomised controlled trials examining pharmacotherapy for methamphetamine dependence | Skip to:
28 min 05 sec |
Robert Stirling
NCCRED Board member Chief Executive Officer, Network of Alcohol and Other Drugs Agencies |
Discussant | Skip to:
39 min 05 sec |
Peter Stockham
Principal Forensic Scientist, Toxicology, Forensic Science SA |
Conclusion of the South Australian Drug Early Warning System – Emergency Department Admission Blood Psychoactive Testing (EDABPT) Study | Skip to:
1 min 15 sec |
Jennifer Smith
Research Project Officer, Centre for Clinical Research in Emergency Medicine, Royal Perth Hospital |
“Brevity of data will take precedence”: evolution of a national minimum dataset of illicit and emerging drugs in the emergency department | Skip to:
10 min 10 sec |
Andrew Kozman
NCCRED Research Fellow, Emergency Consultant, Fiona Stanley Hospital |
The implementation of the Recreational Drug Intoxication Protocol | Skip to:
22 min 50 sec |
Rachel Sutherland
Research Fellow, National Drug and Alcohol Research Centre, University of New South Wales |
Feasibility, consumer acceptability and behavioural outcomes associated with take-home fentanyl test strips | Skip to:
32 min 05 sec |
Jack Nagle
Founder of Realdrugtalk, Member NCCRED Methamphetamine and Emerging Drugs Clinical Research Network Working Group |
Discussant | Skip to:
41 min 35 sec |
In line with NCCRED’s aims, the symposium was designed to:
We gathered vastly experienced clinicians and researchers from some of the major drug and alcohol centres around the country. The program included presentations from Round 1 NCCRED Clinical Research Seed Funding Grant recipients, NCCRED Clinical Research Capacity Building Grant recipients, the NCCRED team and affiliates. They shared the most up-to-date aspects of their work and research around emerging drug use, including:
Check out the program:
National Centre for Clinical
Research on Emerging Drugs
We would like to acknowledge the traditional owners of this country
and pay our respects to Elders past, present and emerging.